Loading
Latest filing published 04 Oct 2024 for DIASORIN, €821k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Carlo Rosa on record concern Diasorin, in the capacity of chief executive. The record holds 9 filings, for trades running from 16 November 2023 to 1 October 2024.
The open-market record consists of 8 sales worth €10.7M, with no purchase. 2024 to date brings no purchases and 8 sales.
The newest entry dates from 4 October 2024: an open-market sale of €821k, in Diasorin. Between a trade and the moment it shows up on Consob, the median delay is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by Consob and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations